week 7- Mental Health and Affective Disorders Sway Flashcards
(42 cards)
what are are risk factors for depressive diorders?
-stress
-chronic stress increases cortisol release from adrenal cortex due to CRH produced in the hypothalamus (HPA axis)
• Genetic factors – high heritability of depressive disorders in twin
studies
• Family history
• Intensive efforts made to find genes linking to depression but GWAS
have given few clues
• Candidate gene studies have identified ~200 genes, SLC6A4 is one
• Substance abuse
what is the first theory for the pathophysicology of depression? what it means?
-monamine theory
-If we identify the cause of depression = we can effectively treat it
-there was a functional deficit of monoamine
neurotransmitters (5-HT and noradrenaline) and dopamine in areas of the brain
-
what is the effect of Tricyclic antideppressants and how do they work?
Block monoamine reuptake Enhance mood
what is the effect of MAO inhibitors and how do they work?
Prevent degradation of
monoamines
Enhance mood
what is the effect of tryptophan and how do they work?
Increase 5-HT synthesis
enhance mood
what is the effect of reserpine and how do they work?
Inhibit monoamine storage Reduce mood
what is the effect of α-Methyltyrosine and how do they work?
Inhibit noradrenaline synthesis
Reduce mood
what is the effect of Methyldopa and how do they work?
Inhibit noradrenaline synthesis
Reduce mood
what neurotransmitters can cause depression?
NA and 5-HT (SEROTONIN)
what are the drug targets for depressive disorders?
- the reuptake transporers for both 5-HT and NA
- they are in the SLC6 family
- known as SERT and NET
what does SERT stand for?
seretonin reuptake transporters
-SLC6A4
what does NET stand for?
Norarenaline reuptake transporters
-SLC6A2
what type of transporter is SERT and NET?
-symporters
-use co-transporter of sodium as a driving force for carrying their substrate (neurotransmitter) across the plasma membrane
-• Dependent on extracellular Cl-
• Some SLC transporters also move K+
what is the structure of SERT?
• 12 transmembrane domains• Intracellular N and C-termini• Large glycosylated EC loop between TM3 and 4 • Alternating access model • Substrate binding site is accessible to either the external or internal medium
how is the substrate is moved across the plasma membrane through SERT?
- substrate and Na+ comes in
- it becomes bound and occuluded
- then transporter opens and the substate and counter transporter ion is rleased
where are SERT and NET found?
on the pre synatic terminals of the seretinergic and noradrenergic neurones
how do reuptake inhibitors work/
-only work once the neurotrasmitters have been released
• Prevent the reuptake of serotonin or NA into the neurons
• Enhances the synaptic levels of serotonin and/or noradrenaline within the synapse and lengthen the amount of time the Neurotrasmitter is avavliable to then bind to the receptor on the post synpatic neuron
what are some examples of of anti-depressants?
• SSRIs:
Fluoxetine, paroxetine, sertraline, citalopram, escitalopram, fluvoxamine
• SNRIs:
Buproprion, reboxetine, atomoxetine
• Mixed (non-selective both):
Venlafaxine, duloxetine
• Tricyclic antidepressants (non selective)
Imipramine, desipramine(selective for NA), amitryptyline, clomipramine
what does SSRI mean?
selective serotonin reuptake
inhibitors
what does SNRI mean?
serotonin & noradrenaline
reuptake inhibitors
WHAT ARE THE CONSEQUENCES OF INCREASED 5-HT AND NA?
• Increased signalling through 5-HT receptors and NA receptors
- Pre-synaptic and post-synaptic
• Gene expression changes, neurogenesis – chronic adaptive changes
how is controlling serotonin levels with reuptake inhibitors?
• Acute action – increases synaptic 5-HT by reducing reuptake
• But 5-HT acts on 5-HT1A on soma/dendrites to inhibit 5-HT release
• This cancels out some of the effect of SSRIs
• Chronic administration – elevated 5-HT level will induce
desensitisation of 5-HT1A receptors
• This in turn will reduce the inhibitory effect of 5-HT
• This need for desensitisation could explain the slow onset of action
how is NA controling 5-HT levels?
• Noradrenaline can control 5-HT release
• NA can act on excitatory α1
receptors to enhance 5-HT release
• α2 receptors are downregulated by antidepressants
• α2 receptor antagonists could
further enhance 5-HT releasee.g. mirtazapine, mianserin
what is monoamine oxidase (MAO)
• Monoamine Oxidase (MAO) controls the degradation of monoamine
neurotransmitters
• There are two forms of MAO –A and B(dopamine preference)
• MAO-A has substrate preference for 5-HT and NA
• Inhibitors of this enzyme will cause an increase in tissue monoamines (5-HT, NA, Dopamine)